{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:57:40Z","timestamp":1779177460695,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijrobp.2022.08.028","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T02:11:55Z","timestamp":1660788715000},"page":"762-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study"],"prefix":"10.1016","volume":"114","author":[{"given":"Pierina","family":"Navarria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Baldaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Marini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia Francesca","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Quagliuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Torri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiuseppe","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Bellu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.08.028_bib0001","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0002","first-page":"147","article-title":"Epidemiology and therapies for metastatic sarcoma","volume":"5","author":"Amankwah","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1200\/JCO.2017.74.9374","article-title":"Contemporary sarcoma diagnosis, genetics, and genomics","volume":"36","author":"Schaefer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0004","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0005","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): A randomised controlled phase 3 trial","volume":"18","author":"Seddon","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-017-0831-7","article-title":"Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: The METASARC observational study","volume":"15","author":"Savina","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: A randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0010","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.21037\/jtd-2019-pm-13","article-title":"Pulmonary metastasectomy in soft tissue sarcomas: A systematic review","volume":"13","author":"Stamenovic","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jso.25504","article-title":"Long-term results of surgical resection of lung metastases from soft tissue sarcoma: A single center experience","volume":"120","author":"Nevala","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0012","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jtcvs.2017.02.061","article-title":"Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma","volume":"154","author":"Chudgar","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0013","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non small-cell lung cancer: A pooled analysis of two randomised trials","volume":"6","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0014","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2012.07.2354","article-title":"Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly","volume":"84","author":"Shirvani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2016.04.012","article-title":"Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases\u2014A pooled analysis of the German working group \u201cstereotactic radiotherapy\u201d","volume":"97","author":"Rieber","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0017","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/1759-7714.12880","article-title":"Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases","volume":"9","author":"Lee","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0019","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.semradonc.2017.03.003","article-title":"Stereotactic ablative body radiotherapy for lung metastases: Where is the evidence and what are we doing with it?","volume":"27","author":"Siva","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0020","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1748-717X-9-91","article-title":"Stereotactic body radiotherapy (SBRT) in lung oligometastatic patients: role of local treatments","volume":"9","author":"Navarria","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0023","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/sim.721","article-title":"Sample size tables for exact single-stage phase II designs","volume":"20","author":"A'Hern","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9132359","article-title":"Treatment of sarcoma lung metastases with stereotactic body radiotherapy","volume":"2018","author":"Lindsay","year":"2018","journal-title":"Sarcoma"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clon.2020.01.005","article-title":"Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma","volume":"32","author":"Tetta","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/COC.0000000000000103","article-title":"Single-institution experience of SBRT for lung metastases in sarcoma patients","volume":"40","author":"Soyfer","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0027","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jso.24268","article-title":"Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection","volume":"114","author":"Baumann","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0028","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ijrobp.2010.11.052","article-title":"Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: Excellent local lesion control and improved patient survival","volume":"82","author":"Dhakal","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0029","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejca.2015.01.061","article-title":"Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma","volume":"51","author":"Navarria","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0030","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s12032-012-0256-2","article-title":"A retrospective study of SBRT of metastases in patients with primary sarcoma","volume":"29","author":"Stragliotto","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0031","first-page":"5581","article-title":"Stereotactic radiotherapy in the treatment of lung metastases from bone and soft-tissue sarcomas","volume":"35","author":"Frakulli","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2022.08.028_bib0032","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622031315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622031315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:58:45Z","timestamp":1759744725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622031315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0360301622031315"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.08.028","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}